Age-related comparison of the profiles of patients with hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 53, Issue 72, 2006, Pages 913-918

  Fujishima, Tomonori ^a   Ishikawa, Takashi ^a   Shiratori, Yasushi ^a   Kanda, Miho ^a   Tateishi, Ryosuke ^a   Akamatsu, Masatoshi ^a   Koike, Yukihiro ^a   Sato, Shinpei ^a   Obi, Shuntaro ^a   Hamamura, Keisuke ^a   Teratani, Takuma ^a   Shiina, Shuichiro ^a   Yoshida, Haruhiko ^a   Kawabe, Takao ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Age; Hepatocellular carcinoma; Young

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; LABORATORY TEST; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 33845224331     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Parkin DM, Stjernsward J, Muir CS: Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 1984; 62:163-182.
2. Okuda K: Early recognition of hepatocellular carcinoma. Hepatology 1986; 6:729-738.
3. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J: Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992; 16:637-641.
4. Nishioka K, Watanabe J, Furuta S, Tanaka E, lino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo QL: A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67:429-433.
5. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328:1797-1801.
6. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2:1004-1006.
7. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2:1006-1008.
8. Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER: Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993; 18:1326-1333.
9. Lee CM, Lu SN, Changchien CS, Yeh CT, Hsu TT, Tang JH, Wang JH, Lin DY, Chen CL, Chen WJ: Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 1999; 86:1143-1150.
10. al Karawi MA, Shariq S, el Shiekh Mohamed AR, Saeed AA, Ahmed AM: Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia. J Gastroenterol Hepatol 1992; 7:237-239.
11. Chang WY, Wang LY, Chuang WL, Chen SC, Lu SN, You SL: Anti-HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: relation to multi-transfusion. J Gastroenterol Hepatol 1992; 7:128-131.
12. Dazza MC, Meneses LV, Girard PM, Astagneau P, Villaroel C, Delaporte E, Larouze B: Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique. Am J Trop Med Hyg 1993; 48:237-242.
13. Di Bisceglie AM, Order SE, Klein JL, Waggoner JG, Sjogren MH, Kuo G, Houghton M, Choo QL, Hoofnagle JH: The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991; 86:335-338.
14. Ramesh R, Munshi A, Panda SK: Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. J Gastroenterol Hepatol 1992; 7:393-395.
15. Pramoolsinsap C, Sumalnop K, Busagorn N, Kurathong S: Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma. Southeast Asian J Trop Med Public Health 1992; 23:6-11.
16. Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L: Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36:962-972.
17. Furuta T, Kanematsu T, Matsumata T, Shirabe K, Yamagata M, Utsunomiya T, Sugimachi K: Clinicopathologic features of hepatocellular carcinoma in young patients. Cancer 1990; 66:2395-2398.
18. Trevisani F, D'Intino PE, Grazi GL, Caraceni P, Gasbarrini A, Colantoni A, Stefanini GF, Mazziotti A, Gozzetti G, Gasbarrini G, Bernardi M: Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Cancer 1996; 77:2223-2232.
19. Edmondson HSteiner P: Primary carcinoma of the liver. Cancer 1954; 7:462-503.
20. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-1520.
21. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, Kawanishi M: A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18:47-53.
22. Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A: Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74:2442-2448.
23. Chiba T, Matsuzaki Y, Abei M, Shoda J, Aikawa T, Tanaka N, Osuga T: Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis. J Gastroenterol 1996; 31:552-558.
24. Johnson PJ, Krasner N, Portmann B, Eddleston AL, Williams R: Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut 1978; 19:1022-1026.
25. Pirovino M, Heer M, Joller-Jemelka HP, Altorfer J, Akovbiantz A, Schmid M: Hepatocellular carcinoma and hepatitis B virus infection. Analysis of 75 cases from Switzerland. Liver 1983; 3:398-402.
26. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-362.
27. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87:6547-6549.
28. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H, Ishibashi H, Maeda Y, Kiyokawa H: Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51:2842-2847.
29. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxi A, Ciccaglione A, Giuseppetti R: Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116:97-102.
30. Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, Hsieh MY, Wang LY, You SL, Chen CJ: The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 1992; 69:2052-2054.
31. Shiratori Y, Yoshida H, Omata M: Different clinicopathological features of hepatocellular carcinoma in relation to causative agents. J Gastroenterol 2001; 36:73-78.
32. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M: Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 1995; 22:1027-1033.
33. Miyagawa S, Kawasaki S, Makuuchi M: Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996; 24:307-310.
34. Tanizaki H, Ryu M, Kinoshita T, Kawano N, Konishi M, Cho A, Nakatsura T, Natsume T, Takahashi S, Sugita M, Izuishi K, Yoshino M, Furuse J, Iwasaki M, Tsubono Y: Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol 1997; 27:67-70.
35. Shirabe K, Shimada M, Kajiyama K, Gion T, Ikeda Y, Hasegawa H, Taguchi K, Takenaka K, Sugimachi K: Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 1998; 83:2312-2316.
36. Chen MF, Jeng LB, Lee WC, Chen TC: Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma. Surgery 1998; 123:554-559.
37. Shuto T, Hirohashi K, Kubo S, Tsukamoto T, Yamamoto T, Wakasa K, Kinoshita H: Differences of resected hepatocellular carcinoma with hepatitis B or C virus. Hepatogastroenterology 1998; 45:1722-1725.
38. Tanabe G, Nuruki K, Baba Y, Imamura Y, Miyazono N, Ueno K, Arima T, Nakajyou M, Aikou T: A comparison of hepatocellular carcinoma associated with HBV or HCV infection. Hepatogastroenterology 1999; 46:2442-2446.
39. Wu CC, Tang JS, Lin MC, Yeh DC, Liu TJ, P'Eng F K: Comparison of liver resection for hepatocellular carcinoma in hepatitis B and hepatitis C-related cirrhotic patients. Hepatogastroenterology 1999; 46:651-655.
40. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Hamba H, Shuto T, Yamamoto T, Ikebe T, Kinoshita H: Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 1999; 86:793-798.
41. Okuda K: Hepatocellular carcinoma: recent progress. Hepatology 1992; 15:948-963.
42. Noda K, Yoshihara H, Suzuki K, Yamada Y, Kasahara A, Hayashi N, Fusamoto H, Kamada T: Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma-its relationship to alcohol drinking and the age of transfusion. Alcohol Clin Exp Res 1996; 20:95A-100A.
43. Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, Mizuhara Y, Hirakawa J, Nakajima H, Fujisawa K: Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993; 88:39-43.
44. Ono E, Shiratori Y, Okudaira T: Platelet count reflects stage of chronic hepatitis C. Hepatol Res 1999; 15:192-200.
45. Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349:825-832.
46. Ku NO, Wright TL, Terrault NA, Gish R, Omary MB: Mutation of human keratin 18 in association with cryptogenic cirrhosis. J Clin Invest 1997; 99:19-23.
47. Ku NO, Gish R, Wright TL, Omary MB: Keratin 8 mutations in patients with cryptogenic liver disease. N Engl J Med 2001; 344:1580-1587.
48. Akuta N, Chayama K, Suzuki F, Someya T, Kobayashi M, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H: Risk factors of hepatitis C virus-related liver cirrhosis in young adults: positive family history of liver disease and transporter associated with antigen processing 2(TAP2)*0201 Allele. J Med Virol 2001; 64:109-116.
49. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, Jonsson JR: Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31:828-833.
50. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY, Tsai JH: Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer 1997; 76:968-974.
51. Donato F, Boffetta P, Puoti M: A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75:347-354.
52. Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, Albertini A, Fasola M, Boffetta P, Nardi G: Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int J Cancer 1999; 81:695-699.
53. Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T: High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 1999; 45:284-288.
54. Dohmen K, Shirahama M, Onohara S, Miyamoto Y, Torii Y, Irie K, Ishibashi H: Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: an analysis of 547 patients. Hepatol Res 2000; 18:110-121.